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ABSTRACT   
  The Dentin Matrix Protein (DMP1) is a critical regulator of bone 
and dentin mineralization and this protein is highly expressed in osteocytes and 
odontoblasts. Gs alpha (Gsα) protein, the main intracellular signal of a broad 
class of G-protein coupled receptors (GPCRs), is highly expressed in bone 
cells, including osteocytes. We and others have demonstrated that mice lacking 
the Gsα expression, predominantly in osteocytes (DMP1-GsαKO mice), 
develop severe osteopenia driven by a marked reduction in osteoblast activity 
associated with a significant increase in SOST/sclerostin expression. In this 
study, we have examined the role of Gsα in the jaws and teeth of DMP1-GsαKO 
mice to investigate if the absence of Gsα expression in osteocytes and 
odontoblasts altered teeth and jaws morphology. Our previous studies showed 
that DMP1-GsαKO leads to a significant decrease in both trabecular and 
cortical bone content in the skeleton, as assessed by μCT and 
histomorphometric analysis. Here we characterize the dental and craniofacial 
phenotype of DMP1-GsαKO mice. Results showed that DMP1-GsαKO had 
decreased total mandibular bone mineral density (BMD), total mandibular 
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mineral content (BMC), condylar BMD and total tooth mineralization as 
assessed by DEXA using a Lunar PIXImus II densitometer. 
Furthermore, μCT analysis revealed that condylar bone volume and 
tooth mineralization is reduced in DMP1-GsαKO mice compared to control 
littermate. μCT also showed that the overall skull size and specifically the 
zygomatic bone is larger in the control group. Next, we examined H&E 
histological sections of the jaws of DMP1-GsαKO and control mice, which 
confirmed the osteopenic phenotype. Tartrate-resistant acid phosphatase 
(TRAP) staining showed that the number of TRAP-positive osteoclasts was 
increased in the DMP1-GsαKO mice compared to controls, suggesting 
increased bone resorption. In conclusion, our studies identified Gsa signaling 
in osteocytes and odontoblasts as important in maintaining normal bone and 
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Osteocytes were long thought to be quiescent cells, but in the early 
2000s they have been identified as the central regulator of bone re-modeling 
by modulating activities of both osteoblasts and osteocytes (1). Similar to 
osteocytes, bone lining cells which have a long life span, also appear as 
quiescent cells. Lineage of the bone lining cells is still unclear. A recent lineage 
tracing study showed that bone lining cells arise from mature osteoblasts (2) 
whereas, another study presented that they have the characteristics of both 
osteoblasts and mesenchymal cells (3), making them a good source of 
functioning osteoblasts during newly initiating bone remodeling (4).  
Role of DMP1  
DMP1 is essential in regulating the mineralization process and thus 
plays an important role in tooth formation, bone, and cartilage development (5, 
6). Several studies reported that enamel mineral composition does not vary 
much between incisors and molars (7). However, tooth mineralization occurs at 
different timings (8). Moreover, this protein is highly expressed in osteocytes 
and odontoblasts. Gs alpha (Gsα), the main intracellular signaling protein of a 
wide class of G-protein coupled receptors (GPCRs), is highly expressed in 
bone cells, including osteocytes (9).  
Parathyroid hormone and bone homeostasis 
GPCRs couple with many receptors such as parathyroid hormone 
receptors (PTHR) and the prostaglandin receptor. PTHRs are critical regulators 
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of bone formation, as shown by a genetic manipulation study targeting early 
osteoblast lineage cells (10). Parathyroid hormone (PTH) stimulates new bone 
formation (11), which signals through the PTHR, which is also a G-protein 
coupled receptor (GPCR) highly expressed in bone, condylar cartilage, and 
kidney (12, 13). PTH has a critical role in calcium and phosphate homeostasis. 
The receptor signals through several pathways, including the stimulatory 
subunit of G-proteins, Gsα. PTH signaling in early osteoblast lineage cells is a 
critical regulator of bone and cartilage formation (10). A recent study showed 
that intermittent PTH administration leads to alteration of the subchondral bone 
microarchitecture and an increased mineralization/calcification of the 
temporomandibular joint cartilage and condyles (14). Here we focus on the 
condyles as they play a significant role in mandibular growth, craniofacial 
anomalies and malocclusions (15). 
 Overexpression of PTH leads to osteoporosis, which is characterized 
by low bone mass and micro-architectural defects that lead to decreased bone 
strength and increased fracture risk. However, in terminally differentiated and 
most abundant bone cells, osteocytes, loss of PTH signaling results in an 
increase in bone mineral density (16). On the other hand, Gsα signaling in early 
osteoblast lineage cells has more profound effects on skeletal homeostasis (17, 
18). Mechanical stimulation is also a well-known anabolic signal for bone 
formation. Ultrastructural studies showed that mechanical stimulation induces 
bone lining cells along the trabecular bone surface to differentiate into 
osteoblastic cells of which characteristics include increased cuboidal shape, 
rounded nuclei, and abundant rough endoplasmic reticulum (19). 
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Sclerostin and PTH 
Expression of sclerostin, a glycoprotein secreted by osteocytes, is highly 
suppressed by PTH and mechanical forces (20, 21). It has been shown that 
higher sclerostin levels reduce endosteal osteoblasts and that the normalization 
of high sclerostin levels by anti-sclerostin antibody restores these cells. These 
findings are consistent with the effects of PTH and mechanical stimulation in 
these cells (19, 22, 23). In a previous study, the treatment of DMP1-GsαKO 
mice with anti-sclerostin antibody showed a significant increase in the numbers 
of osteocalcin-positive cells on the endosteal bone surface. This was 
accompanied by an increase in serum levels of PINP, indicating an increase in 
active bone-forming osteoblasts. Interestingly, serum levels of CTX were also 
increased, suggesting the osteoblast-osteoclast coupling was also increased 
(4).  
As the central regulator of bone remodeling, osteocytes are thought to 
maintain the bone lining cells in the quiescence state via sclerostin secretion. 
They suppress sclerostin secretion, in response to numerous signals, when a 
new bone remodeling cycle is needed. Numerous studies have shown that Gsα 
signaling in osteocytes is a potent regulator of sclerostin expression and 
secretion (24-26). Upstream of the Gsα signaling, PTH signaling through its G-
protein coupled receptor, PTHR, is a major ligand influencing bone 
homeostasis, at least in part, by inhibiting sclerostin (16, 17, 27, 28). 
Downstream of the Gsα signaling, transcription factors such as Mef2C, HDAC4, 




Effect of GsαKO in osteocytes and bone homeostasis 
To better understand the Gsα signaling pathway in craniofacial bone 
homeostasis, we examined the role of Gsα signaling in osteocytes.  Previous 
studies have reported that mice lacking Gsα in osteocytes (DMP1-GsαKO 
mice) and mature osteoblasts (Oc-GsαKO) had increased SOST/sclerostin 
expression and marked osteopenia (24, 25). It has been previously reported 
that intermittent PTH administration converts quiescent endosteal bone lining 
cells into functional osteoblasts (22) and that bone lining cells are a major 
source of proliferating preosteoblasts and mature osteoblasts (2). These newly 
formed osteoblasts from bone lining cells actively contribute to bone remodeling 
in adults and respond to both catabolic and anabolic bone stimuli (2). The bone 
lining cells express genetic signature markers of both MSCs and osteoblasts 
such as RANKL (2).  
The severe osteopenia present in DMP1-GsαKO mice is due to dramatic 
suppression of bone formation with loss of trabecular and endosteal 
osteoblasts, partially driven by elevated SOST/sclerostin levels.  A previous 
study examined the skeletal phenotype of mice lacking Gsα in osteocytes and 
some mature osteoblasts (DMP1- GsαKO mice) and reported that these mice 
have severe osteopenia, increased myeloid cells and browning of white 
adipose tissue (24, 25). This is consistent with other studies showing dramatic 
osteopenia in mice lacking Gsα in pre-osteoblasts (osterix-GsαKO) osteoblasts 
(Coll1- GsαKO) and mature osteoblasts (Oc-GsαKO) (17, 25, 29). Also, it has 
been shown clinically that patients whom have reduced Gsa expression suffer 
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from Pseudohypoparathyroidism (30, 31). 
  Given the role of GSa signaling in regulating both endosteal osteoblasts 
and cartilage, we hypothesized that this protein is critical for tooth 





































MATERIALS AND METHODS 
Mice  
 
 Twenty-eight, 6-week-old mice were used (Gsa fl/fl or Control: N=16; 7M 
and 9F, DMP1-Cre+Gsa fl/fl or KO: N=12; 3M and 9F). All experimental animal 
procedures were approved by the Institutional Animal Care and Use Committee 
(IACUC) of Boston University Medical Campus (protocol #15522). DMP1-
Cre(+): Gsα(flox/flox) mice were generated by crossing Gsαflox/flox mice (32) 
with mice expressing Cre-recombinase driven by a 10 kb DMP1-promoter (33). 
Littermates lacking Cre-expression were used as controls for all experiments 
(Gsa fl/fl). The genotype of all experimental mice was determined by PCR 
analysis of genomic DNA extracted from tail biopsies using following primers: 
Cre- transgene: forward 5′-CGCGGTCTGGCAGTAAAAACTATC-3′ and 
reverse: 5′-CCCACCGTCAGTACGTGAGATATC-3′; Gsα allele: forward: 5′-
GAGAGCGAGACGAAGACAGC-3′ and reverse: 5′-TCGGGCCTCTGGC 
GGAGCTT-3′. Mice were euthanized at six weeks of age, and mice heads were 
harvested and processed for further analyses. 
Dual Energy X-ray Absorptiometry (DEXA)  
 
Total bone mineral density (BMD), total mineral content (BMC), condyles 
BMD, and incisor mineralization were quantitatively assessed by DEXA using 
a Lunar PIXImus II densitometer Prodigy Advance machine with software 
package 13.60. DEXA values were based on three regions of interest (ROI). 
The first ROI (ROI1) was the whole mandible. The second ROI (ROI2) was the 





Bone microarchitecture was quantitatively assessed with high-resolution 
micro-computed tomography (μCT40; Scanco Medical, Brüttisellen, 
Switzerland). The mandible and full head of mice were scanned using 70 kVp, 
50 mAs, and 12-μm isotropic voxel size. For the condylar region, we assessed 
total mineral density (TMD) and bone volume fraction (BV/TV, %) by contouring 
and measuring the condyle's mushroom-shaped head. Scanning and analyses 
adhered to recently published guidelines (34). Also, three specific linear 
measurements of the mandible were performed; mandibular length, condyle 
head length, and condyle head width using ImageJ, as described by O’ Brien 
(14). 
 Tissue Processing  
 
The head and the lower jaw were harvested, weighed and processed for 
µCT, histology, immunohistochemistry analyses when the mice were six-week 
old, where we have seen the most effect of osteopenia (4). The mandibles were 
dissected free by cutting the muscular attachments and were cut in half for µCT 
analysis while the other half was decalcified with 20% EDTA. After 
decalcification, samples were processed, and paraffin-embedded, and 5 µm 
serial sections were placed on OptiPlus Positive-Charged Barrier Slides 
(BioGenex, Fremont, CA), deparaffinized with xylene/ ethanol and processed 





Mice mandibles were fixed overnight in 4% paraformaldehyde in PBS 
and dehydrated. Samples were processed, decalcified in 20 % EDTA for four 
weeks and later embedded in paraffin and sectioned (5-µm thickness) and 
stained with hematoxylin and eosin (H&E). Digital images of stained slides were 
acquired with EVOS® FL Cell Imaging System (Thermo Fisher Scientific, 
Waltham, MA). 
 
Tartrate-resistant acid phosphatase (TRAP) staining 
 
Paraffin sections were deparaffinized and rehydrated in TBS. The slides 
were then incubated for 45 min at 37 °C in 0.92% sodium acetate buffer, pH 
5.0, containing 0.01% naphthol AS-BI phosphate, and 1.14% L-(+)Tartaric acid. 
Then, the sections were incubated in the same buffer containing 0.1% 
pararosaniline chloride for 10 min, followed by washing in distilled water. The 
sections were dehydrated in ethanol and xylene, and coverslipped with 
mounting media. TRAP-positive cells were quantified in 6-fields near the growth 
plate. Digital images of stained slides were acquired with EVOS® FL Cell 
Imaging System from Thermo Fisher Scientific. 
 
Statistical Analyses 
Statistics for comparing relative abundances of BMD, BMC, 
mineralization content, and osteocyte counts obtained using DEXA, µCT, H&E 
and TRAP assays, between DMP1-Cre(+): Gsα(flox/flox) and Gsα(flox/flox)  
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(control) groups were obtained using an unpaired two-tailed t-test. All data 
shown represent the mean and standard error of the mean (SEM). Statistically 
significant differences between groups were determined by using GraphPad 
Prism. The level of significance is designated as follows: *: p < 0.05, **: p < 




















Mice lacking Gsα in osteocytes have decreased craniofacial bone 
volume  
We have previously generated mice lacking Gsα in osteocytes by mating 
Gsα(flox/flox) mice (35)  with mice expressing Cre-recombinase driven by 
dentin matrix protein 1 (DMP1) (36). Therefore, DMP1-Cre(+): Gsα(flox/flox) 
mice are referred to as DMP1-GsαKO, and littermates lacking DMP1-Cre 
expression were used as controls (WT). We have reported that the 10KbDMP1-
Cre, albeit highly expressed in osteocytes, is also expressed in some mature 
osteoblasts and skeletal muscle (25). As previously reported, DMP1-GsαKO 
animals have low bone mass, decrease adipose tissue, and develop a 
myeloproliferative phenotype (24). To examine the effect of Gsα-deletion in 
osteocytes and some mature osteoblasts on craniofacial homeostasis, we 
examined the quantitative bone analysis by DEXA using a Lunar PIXImus II 
densitometer. We also examined the alteration of the craniofacial bones by 
micro-computed tomography. We analyzed the bones in young (6-week old) 
male and female animals. DEXA quantitative evaluation of full jaw showed that 
both the total bone mineral density (BMD) and total bone mineral content (BMC) 
were decreased in the mandible of 6-week old DMP1-GsαKO female mice 











Figure 1. Mice lacking Gsα in osteocytes are osteopenic (A). Region of interest 
(ROI) 1 used to calculate total BMD and BMC for the mandible by DEXA scan. 
(B). Quantitative DEXA parameters for the mandible showing 6-week old 
female control and DMP1-GsαKO mice (WT: N=8, KO: N=6). All data: shown 
as the mean (+SEM) (Unpaired t-test; ** P < 0.005). 
 
Also, qualitative micro-CT reconstructions of the mandible showed that 
the overall bone structure phenotype appeared to have lower mineral density 
in DMP1-GsαKO compared to control in both the buccal and lingual view 




















































Figure 2. Mice lacking Gsα in osteocytes are osteopenic. (A, B). Buccal and 
lingual view of the mandible showing the phenotype with reconstruction by µCT 
scan for 6-week old female control and DMP1-GsαKO mice. 
 
 
In addition, the overall skull size of DMP1-GsαKO mice was smaller than 
controls, especially in the zygomatic region (Figure 3). These data show that 
the loss of Gsα signaling in osteocytes is critical for both cortical and trabecular 
bone accumulation in craniofacial bones. 
 
 






















Figure 3. Mice lacking Gsα in osteocytes are osteopenic. Top view of the whole 
head showing the phenotype with reconstruction by µCT scan. Overall, skull 
size was smaller, especially in the zygomatic region (Arrow) of DMP1-GsαKO 









GsaKO (Dmp1-Cre; Gsa fl/fl) GsaWT (Gsa fl/fl) 
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Condylar bone lining cells are decreased in DMP1-GsαKO mice 
Given the critical role condyles play in mandibular growth and 
craniofacial anomalies, we examined the condyle alone to specifically study the 
effect of Gsa.  In order to examine the effect of Gsα-deletion in osteocytes and 
some mature osteoblasts on the condyle, we further analyzed the outcome of 
that region with DEXA and µCT scans. Also, we stained the joint with H&E to 
examine them histologically. We examined bones in young (6-week old) female 
animals for quantitative bone analysis by DEXA using a Lunar PIXImus II 
densitometer. We also carried on with quantitative and qualitative bone analysis 
by micro-computed tomography. DEXA quantitative evaluation of the condyles, 
ROI 2, showed a significant reduction in the bone mineral density (BMD) in the 
condyles of 6-week old DMP1-GsαKO female mice compared to wild type 










Figure 4. Degenerative changes in DMP1-GsαKO condyles. (A). Region of 
interest (ROI) 2 used to calculate the BMD for the condylar head by DEXA scan. 
(B). Quantitative DEXA parameters for the condyles showing 6-week old female 
control and DMP1-GsαKO mice (WT: N=8, KO: N=6). All data: shown as the 































Moreover, μCT quantitative analysis also showed a reduction in the 
condyles BMD of 6-week old DMP1-GsαKO female mice compared to control 
as we saw in the DEXA scan (Figure 5). Also, we can appreciate the differences 
in bone quality that we can observe between both groups. Interestingly we see 
remarkable osteopenia in the condyle of DMP1-GsαKO compared to the control 
group (Figure 5A). µCT quantitative analysis shows a significant reduction in 
the BMD of the condyles and the BV/TV, which explains the changes in the 
condylar trabecular bone, as shown in Figure 7. 
 
A 
GsaWT (Gsa fl/fl)  





















Figure 5. Degenerative changes in DMP1-GsαKO condyles. (A) Reconstruction 
of the mandible by µCT scan showing the difference in bone quality and 
highlighting the condyles as contoured with the red dots (B) Quantitative 
measurement for the condyles BMD for the 6-week old female control and 
DMP1-GsαKO mice (WT: N=8, KO: N=6). All data: shown as the mean (+SEM) 
(Unpaired t-test; * P < 0.05). 
 
 
The mandibular length, condylar head length and condylar head width 
linear measurements were further assessed. Interestingly, there was a 
statistically significant reduction in the mandibular length and the condylar head 
length of 6-week old DMP1-GsαKO female mice compared to control (Figure 
6). However, the condylar width of 6-week old DMP1-GsαKO female mice 






















































































Figure 6. The mandibular length (red), condylar head length (blue) and condylar 
head width (yellow) linear measurements. Mandibular length and the condylar 
head length of 6-week old DMP1-GsαKO female mice showing a significant 
reduction in length compared to control. and DMP1-GsαKO mice (WT: N=3, 
KO: N=3). Condylar width of 6-week old DMP1-GsαKO female mice is less 
compared to wild type but it’s not significant. *Statistically significant 






















































































































































































H&E staining showed that endosteal osteoblasts in cortical bone regions 
were significantly reduced in the condyles of DMP1-GsαKO mice compared to 
GsαWT (Figure. 7). Tartrate resistant acid phosphatase staining further 
confirmed that the number of TRAP-positive osteoclasts was significantly 
increased in the DMP1-GsαKO mice (Figure 8). Interestingly, this overlaps with 
the area with the most bone resorption we observed in the H&E staining 






Figure 7. Degenerative changes in DMP1-GsαKO condyles. Condyles were 
analyzed by H&E staining for differences in histology. (A) GsαWT characterized 
by normal bone structure, in contrast to (B) DMP1-GsαKO condyles that 
exhibited loss of bone structure. 
 
 
GsaWT (Gsa fl/fl) 10x GsaWT (Gsa fl/fl) 20x  














Figure 8. Degenerative changes in DMP1-GsαKO condyles. Condyles were 
analyzed by tartrate-resistant acid phosphatase staining to identify osteoclasts. 
(A) GsαWT was characterized by lower osteoclast count compared to (B) 
DMP1-GsαKO condyles that exhibited more TRAP+ cells, suggesting a more 
osteoclastic activity. (C) Quantification of TRAP-positive osteoclastic cells (WT: 































GsaWT (Gsa fl/fl) 10x GsaWT (Gsa fl/fl) 20x 











Effect of Gsa deficiency on tooth mineralization  
 
Given that DMP1 plays a significant role in tooth development (5) , we 
asked if tooth mineralization is affected in the Dmp1-Cre; Gsa fl/fl mice model. 
We imaged samples by DEXA using a Lunar PIXImus II densitometer to 
measure incisors mineral content by identifying a region of interest that was 
drawn around the incisors, ROI 3, and it showed less mineral content in Dmp1-
Cre; Gsa fl/fl mice. Therefore, a significant reduction in enamel mineral content 
was observed in DMP1-GsαKO mice (Figure 9). 
 
Furthermore, we used µCT imaging to compare mineral content in both 
incisors and molars. It is more accurate to measure each region alone because 
tooth mineralization occurs at different timings (8). We contoured molars and 
incisors separately, as shown in (Figure 10A). We then measured the mineral 
content in young (6-week old) female animals. µCT quantitative evaluation of 
both molars and incisors showed that the enamel mineralization content was 
decreased in the teeth of 6-week old DMP1-GsαKO female mice compared to 














Figure 9. Effect of Gsa ablation on tooth mineralization. (A). Region of interest 
(ROI) 3 used to calculate the mineralization content for the incisors by DEXA 
scan. (B). Quantitative measurements for the incisors' mineralization content 
showed 6-week old female control and DMP1-GsαKO mice (WT: N=8, KO: 









































Figure 10. Effect of Gsa ablation on tooth mineralization. (A) Reconstruction of 
the mandible by µCT scan showing the subtraction of enamel from all other 
structures in the mandible (i.e., bone, dentin, and cementum) (B) Quantitative 
measurements for the mineralization content in both incisors and molars, all 
teeth, for the 6-week old female control and DMP1-GsαKO mice (WT: N=8, KO: 












































































• Mice lacking the Gsα expression predominantly in osteocytes (DMP1-
GsαKO) develop severe osteopenia in the craniofacial bones and 
condyles specifically.  
 
• Gsa signaling in osteocytes and odontoblasts is essential in maintaining 
normal bone and tooth homeostasis. 
 
 
• In the absence of Gsa signaling in osteocytes and odontoblasts, there is 
a significant increase in osteoclasts. 
 
 
• Gsa signaling affects the mineralization of enamel; thus, it might play an 
important role in tooth formation.  
 
• Gsa signaling plays an integral part in condylar remodeling; thus, it might 








In this study, we examined the craniofacial phenotype of mice lacking 
Gsα in osteocytes and some mature osteoblasts (DMP1-GsαKO mice). We 
have previously reported that these mice have severe skeletal osteopenia in 
the femur and tibia (4). A similar phenotype was also present in mice lacking 
Gsα in both mature osteoblasts and osteocytes (Oc-GsαKO mice), suggesting 
that phenotype is mostly driven by lack of Gsα in osteocytes. Initial studies 
demonstrated a significant increase of sclerostin in the serum of DMP1-GsαKO 
animals. These animals express high sclerostin levels and have marked 
osteopenia. A recent study has identified the role of sclerostin in the bone 
phenotype of DMP1-GsαKO mice and treated these animals with anti-sclerostin 
antibodies (4). They reported that sclerostin neutralizing antibody treatment 
was capable of restoring the number of endosteal osteoblasts to normal levels 
(4). They also found that high sclerostin levels reduce the numbers of newly 
formed osteocytes, and anti-sclerostin antibody treatment restores the 
osteoblast-to-osteocyte transition process (4). The sclerostin neutralizing 
antibody has a potent bone anabolic effect in mice and osteoporotic patients 
(37-39). The bone anabolic effect is due to increased osteoblast numbers and 
activity (37, 40). 
Teeth movements in orthodontic treatment occur due to the coupling of 
bone formation and bone resorption (41) in which both jaws go through 
continuous remodeling. Remodeling is regulated by mechanical factors such 
as the force we apply to move teeth or molecular factors, i.e., hormones. 
Several hormones, including PTH, promote bone anabolism, by stimulating 
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osteoblasts. In osteocytes, PTH exerts its bone-forming effect by suppressing 
SOST expression. Therefore, as an example of clinical implications, anti-
sclerostin antibodies can be beneficial in orthodontics. On many occasions, an 
absolute anchorage is needed when we move teeth, and currently, we use 
temporary anchorage devices (TADs) to gain anchorage. The most common 
type of TADs used is a mini-screw that is inserted in the cortical bone between 
adjacent roots. However, there are anatomical limitations to when we can use 
the mini-screws, so an alternative would be mini-plates inserted in the 
zygomatic process, which will require surgery. Therefore, a better alternative is 
to use a chemical anchorage concept by local injections of anti-sclerostin 
antibodies to the desired location/area.  Although it's not the scope of this study, 
it's relevant to how we can clinically benefit from anti-sclerostin antibody in 
orthodontics. 
The DMP1-GsαKO mice showed osteopenia in both craniofacial (for 
example, the mandible) and the condyles. This is consistent with other studies 
showing dramatic osteopenia in the femur and tibia of DMP1-GsαKO (4) as well 
as mice lacking Gsα in pre-osteoblasts (osterix-GsαKO) and mature 
osteoblasts (Oc-GsαKO) (17, 25, 29).  Our results demonstrate that the 
condyles undergo more active osteoclastic activity, as shown by an increase in 
tartrate-resistant acid phosphatase staining, which overlapped with the bone 
resorption area we observed in H&E staining suggesting increased osteoclastic 
activity. A similar outcome has been reported with cartilage degenerations due 
to cross-talks between PTH and local factors such as BMPs, Wnts, and TGFB 
signaling pathway (14). The condyle is an important landmark in orthodontics, 
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as in some cases, condylar resorption would cause open bites and non-
functional bite (42).  Therefore, understanding the molecular basis of condylar 
remodeling, and how to alter it, is critically important.  
DMP1 is essential in regulating the mineralization process and thus 
plays a vital role in tooth formation, bone, and cartilage development (5, 6). Our 
results show that Gsa's knockout resulted in reduced mineralization content in 
both incisors and molars, as shown by DEXA using a Lunar PIXImus II 
densitometer and µCT scans. In orthodontics, healthy enamel is required to 
place brackets for braces or attachments for clear aligner treatment to be able 
to proceed with tooth movement (43). Therefore, bonding is a very critical step 
in orthodontic mechanotherapy. We aim to find ways to intervene with enamel 
mineralization while teeth are forming through DMP1 and GSa signaling. 
While analyzing the axial view of the head of DMP1-GsαKO and wild 
type mice, we noticed that mice lacking Gsα in osteocytes have a cleft palate. 
In a future study, we are planning to investigate cleft palate with Gsa.  We also 
plan to assess the furcation area and the periodontal ligament (PDL) for any 










Here, we show Gsa's importance and how it could affect the future of 
orthodontic treatment regarding anchorage requirements, craniofacial growth, 
and tooth mineralization. Our study identified Gsa signaling in osteocytes and 
odontoblasts as an essential factor in maintaining normal bone and tooth 
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